Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1045

Article ID: 703934

Scientists Identify Potential New Treatment Strategy for Kidney Cancer

Thomas Jefferson University

New study suggests activation of the protein ISGF3 could be a novel therapeutic strategy for patients with clear cell renal cancer.

Released:
13-Nov-2018 3:30 PM EST
Embargo will expire:
15-Nov-2018 11:00 AM EST
Released to reporters:
13-Nov-2018 11:05 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 15-Nov-2018 11:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
18-Nov-2018 6:00 PM EST
Released to reporters:
13-Nov-2018 10:20 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 18-Nov-2018 6:00 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Charytan_David_inline.jpg

Article ID: 703850

Prominent Cardiovascular & Renal Disease Expert Named Director of Nephrology at NYU Langone Health

NYU Langone Health

David Charytan, MD, renowned expert in cardio-renal disease, named new division director of nephrology at NYU Langone.

Released:
13-Nov-2018 9:00 AM EST

Article ID: 703853

Mount Sinai Technology Spinout RenalytixAI Completes Initial Public Offering, Raising $29 Million to Combat Kidney Disease

Mount Sinai Health System

RenalytixAI PLC, a Mount Sinai exclusive licensee and development collaborator, had completed a public listing that valued the company at $85 million on the London Stock Exchange’s Alternative Investment Market.

Released:
13-Nov-2018 8:20 AM EST
Embargo will expire:
15-Nov-2018 5:00 PM EST
Released to reporters:
9-Nov-2018 2:05 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 15-Nov-2018 5:00 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

phillips.jpeg

Article ID: 703351

Myth Busted: Researchers Show That a High-Protein Diet Does Not Affect Kidney Function

McMaster University

A widely held and controversial myth that high-protein diets may cause kidney damage in healthy adults has been debunked by scientists at McMaster University, who examined more than two dozen studies involving hundreds of participants.

Released:
5-Nov-2018 7:05 AM EST
  • Embargo expired:
    1-Nov-2018 5:00 PM EDT

Article ID: 702873

Study Points to Insurance-Related Disparities in Timely Access to Gold Standard Dialysis Procedure

American Society of Nephrology (ASN)

• In a study that compared uninsured patients starting hemodialysis with similar patients already covered by Medicare or Medicaid, patients with Medicare or Medicaid were more likely to receive dialysis through an arteriovenous fistula or graft by their fourth dialysis month. • Patients with Medicare at the start of dialysis also had fewer hospitalizations involving vascular access infection in dialysis months 4-12.

Released:
26-Oct-2018 10:05 AM EDT
RH.png
  • Embargo expired:
    1-Nov-2018 9:00 AM EDT

Article ID: 703131

American Society of Nephrology Announces 2019-2021 Kidney Health Initiative Co-Chair

American Society of Nephrology (ASN)

The American Society of Nephrology (ASN) today announced former ASN President Raymond C. Harris, Jr., MD, FASN, will serve as co-chair for its Kidney Health Initiative (KHI). Harris, a professor of medicine, molecular physiology, and biophysics, is Director of the Vanderbilt Center for Kidney Disease and former chief of the nephrology division of Vanderbilt University’s Medical Center in Nashville, Tenn.

Released:
31-Oct-2018 10:05 AM EDT

Showing results

110 of 1045

Chat now!